3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Gynecologic
1
Conditions
Brain Neoplasms
5
Neoplasms
3
Lung Neoplasms
2
Uterine Cervical Neoplasms
1
Thyroid Neoplasms
1
Supratentorial Neoplasms
1
Stomach Neoplasms
1
Seizures
1
Prostatic Neoplasms
1
Postoperative Complications
1
Pancreatic Neoplasms
1
Pain
1
Ovarian Neoplasms
1
Ovarian Cysts
1
Neoplasm Metastasis
1
Myofibroma
1
Liver Neoplasms
1
Hematologic Diseases
1
Endobronchial Metastases
1
Encephalocele
1
Ear Neoplasms
1
Cholecystitis
1
Breast Neoplasms
1
Brain Injuries
1
Interventions
Misoprostol
5
Uterine Myomectomy
4
Saline Solution
3
Hysterectomy
3
dienogest
2
carbetocin
2
Tranexamic Acid
2
Tourniquets
2
Lidocaine
2
Hysteroscopy
2
Ascorbic Acid
2
remimazolam
1
relugolix
1
ramosetron
1
Vasopressins
1
Uterine Artery Embolization
1
Triptorelin Pamoate
1
Surveys and Questionnaires
1
Surgical Procedures, Operative
1
Sodium Chloride
1
Sevoflurane
1
Respiration, Artificial
1
Remifentanil
1
Propofol
1
Population Groups
1
Oxytocin
1
Observation
1
Nuclear Receptor Subfamily 4, Group A, Member 2
1
Morcellation
1
Methylergonovine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Myofibroma
×
Remifentanil
×
Clear all
NCT01937104
2014-10-30
ONSD
Chosun University Hospital
Phase NA
Completed
60 enrolled